vs

Side-by-side financial comparison of biote Corp. (BTMD) and CORE MOLDING TECHNOLOGIES INC (CMT). Click either name above to swap in a different company.

CORE MOLDING TECHNOLOGIES INC is the larger business by last-quarter revenue ($74.7M vs $46.4M, roughly 1.6× biote Corp.). On growth, CORE MOLDING TECHNOLOGIES INC posted the faster year-over-year revenue change (19.5% vs -6.9%). biote Corp. produced more free cash flow last quarter ($6.5M vs $-2.9M). Over the past eight quarters, biote Corp.'s revenue compounded faster (-0.4% CAGR vs -2.2%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

Core Molding Technologies, Inc. was founded in 1988 and now based in Columbus, Ohio. The company manufactures sheet molding compounds (SMC), and molds fiberglass reinforced plastics. It occupies over 1,000,000 square feet of manufacturing space and its main subsidiaries are in Matamoros, Mexico, Gaffney, South Carolina, and Cincinnati, Ohio. In 2011, Core Molding Technologies formed Core Specialty Composites, LLC.

BTMD vs CMT — Head-to-Head

Bigger by revenue
CMT
CMT
1.6× larger
CMT
$74.7M
$46.4M
BTMD
Growing faster (revenue YoY)
CMT
CMT
+26.4% gap
CMT
19.5%
-6.9%
BTMD
More free cash flow
BTMD
BTMD
$9.4M more FCF
BTMD
$6.5M
$-2.9M
CMT
Faster 2-yr revenue CAGR
BTMD
BTMD
Annualised
BTMD
-0.4%
-2.2%
CMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
CMT
CMT
Revenue
$46.4M
$74.7M
Net Profit
$2.0M
Gross Margin
15.2%
Operating Margin
14.7%
4.8%
Net Margin
4.2%
Revenue YoY
-6.9%
19.5%
Net Profit YoY
-47.2%
EPS (diluted)
$0.05
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
CMT
CMT
Q4 25
$46.4M
$74.7M
Q3 25
$48.0M
$58.4M
Q2 25
$48.9M
$79.2M
Q1 25
$49.0M
$61.4M
Q4 24
$49.8M
$62.5M
Q3 24
$51.4M
$73.0M
Q2 24
$49.2M
$88.7M
Q1 24
$46.8M
$78.1M
Net Profit
BTMD
BTMD
CMT
CMT
Q4 25
$2.0M
Q3 25
$8.2M
$1.9M
Q2 25
$3.2M
$4.1M
Q1 25
$13.7M
$2.2M
Q4 24
$3.7M
Q3 24
$10.7M
$3.2M
Q2 24
$-7.1M
$6.4M
Q1 24
$-4.2M
$3.8M
Gross Margin
BTMD
BTMD
CMT
CMT
Q4 25
15.2%
Q3 25
17.4%
Q2 25
18.1%
Q1 25
19.2%
Q4 24
15.8%
Q3 24
16.9%
Q2 24
20.0%
Q1 24
17.0%
Operating Margin
BTMD
BTMD
CMT
CMT
Q4 25
14.7%
4.8%
Q3 25
17.2%
4.4%
Q2 25
22.0%
6.6%
Q1 25
19.8%
4.6%
Q4 24
5.6%
1.4%
Q3 24
23.7%
4.9%
Q2 24
12.7%
8.4%
Q1 24
22.3%
6.1%
Net Margin
BTMD
BTMD
CMT
CMT
Q4 25
4.2%
Q3 25
17.1%
3.2%
Q2 25
6.5%
5.1%
Q1 25
28.0%
3.6%
Q4 24
7.4%
Q3 24
20.8%
4.3%
Q2 24
-14.4%
7.2%
Q1 24
-8.9%
4.8%
EPS (diluted)
BTMD
BTMD
CMT
CMT
Q4 25
$0.05
$0.35
Q3 25
$0.22
$0.22
Q2 25
$0.10
$0.47
Q1 25
$0.37
$0.25
Q4 24
$0.09
$-0.01
Q3 24
$0.33
$0.36
Q2 24
$-0.21
$0.73
Q1 24
$-0.12
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
CMT
CMT
Cash + ST InvestmentsLiquidity on hand
$24.1M
$38.1M
Total DebtLower is stronger
$103.1M
$17.6M
Stockholders' EquityBook value
$-58.5M
$158.2M
Total Assets
$107.6M
$228.1M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
CMT
CMT
Q4 25
$24.1M
$38.1M
Q3 25
$28.0M
$42.4M
Q2 25
$19.6M
$43.2M
Q1 25
$41.7M
$44.5M
Q4 24
$39.3M
$41.8M
Q3 24
$38.2M
$42.3M
Q2 24
$26.4M
$37.8M
Q1 24
$78.8M
$26.6M
Total Debt
BTMD
BTMD
CMT
CMT
Q4 25
$103.1M
$17.6M
Q3 25
$104.7M
$18.2M
Q2 25
$106.3M
$18.8M
Q1 25
$107.8M
$19.2M
Q4 24
$109.4M
$19.7M
Q3 24
$110.9M
$20.2M
Q2 24
$112.5M
$20.6M
Q1 24
$114.1M
$21.1M
Stockholders' Equity
BTMD
BTMD
CMT
CMT
Q4 25
$-58.5M
$158.2M
Q3 25
$-72.8M
$155.4M
Q2 25
$-85.1M
$153.5M
Q1 25
$-90.0M
$149.9M
Q4 24
$-105.9M
$147.4M
Q3 24
$-130.3M
$147.8M
Q2 24
$-143.2M
$147.5M
Q1 24
$-36.0M
$142.8M
Total Assets
BTMD
BTMD
CMT
CMT
Q4 25
$107.6M
$228.1M
Q3 25
$111.3M
$219.7M
Q2 25
$104.8M
$219.9M
Q1 25
$123.4M
$223.6M
Q4 24
$122.4M
$209.6M
Q3 24
$101.3M
$220.7M
Q2 24
$92.9M
$225.7M
Q1 24
$160.1M
$212.3M
Debt / Equity
BTMD
BTMD
CMT
CMT
Q4 25
0.11×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
CMT
CMT
Operating Cash FlowLast quarter
$7.6M
$5.0M
Free Cash FlowOCF − Capex
$6.5M
$-2.9M
FCF MarginFCF / Revenue
14.0%
-3.9%
Capex IntensityCapex / Revenue
2.3%
10.7%
Cash ConversionOCF / Net Profit
3.87×
TTM Free Cash FlowTrailing 4 quarters
$30.2M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
CMT
CMT
Q4 25
$7.6M
$5.0M
Q3 25
$14.1M
$4.6M
Q2 25
$7.1M
$3.5M
Q1 25
$6.5M
$6.1M
Q4 24
$12.4M
$5.0M
Q3 24
$15.6M
$9.2M
Q2 24
$9.9M
$15.9M
Q1 24
$7.4M
$5.1M
Free Cash Flow
BTMD
BTMD
CMT
CMT
Q4 25
$6.5M
$-2.9M
Q3 25
$13.6M
$-346.0K
Q2 25
$5.3M
$880.0K
Q1 25
$4.8M
$4.3M
Q4 24
$10.7M
$509.0K
Q3 24
$14.0M
$7.0M
Q2 24
$7.4M
$13.0M
Q1 24
$6.7M
$3.2M
FCF Margin
BTMD
BTMD
CMT
CMT
Q4 25
14.0%
-3.9%
Q3 25
28.3%
-0.6%
Q2 25
10.8%
1.1%
Q1 25
9.9%
7.0%
Q4 24
21.5%
0.8%
Q3 24
27.3%
9.6%
Q2 24
15.1%
14.6%
Q1 24
14.2%
4.1%
Capex Intensity
BTMD
BTMD
CMT
CMT
Q4 25
2.3%
10.7%
Q3 25
1.0%
8.4%
Q2 25
3.7%
3.3%
Q1 25
3.3%
2.9%
Q4 24
3.4%
7.2%
Q3 24
3.0%
3.1%
Q2 24
5.1%
3.3%
Q1 24
1.5%
2.4%
Cash Conversion
BTMD
BTMD
CMT
CMT
Q4 25
3.87×
Q3 25
1.72×
2.44×
Q2 25
2.22×
0.86×
Q1 25
0.47×
2.79×
Q4 24
3.34×
Q3 24
1.45×
2.92×
Q2 24
2.47×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

CMT
CMT

Segment breakdown not available.

Related Comparisons